Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer

Journal of Surgical Oncology

Volumn 107, Issue 6, 2013, Pages 602-607

  Kimbrough, Charles W ^a   St Hill, Charles R ^a   Martin, Robert C G ^a   McMasters, Kelly M ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

lymph nodes; microvascular invasion; pancreatic cancer; resection margins; surgical technique; survival

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; INTRAOPERATIVE PERIOD; LUNG DISEASE; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876417773     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23299     Document Type: Article

References (32)

1. Society AC:, Cancer facts & figures 2012. Atlanta: American Cancer Society; 2011.
2. Yeo CJ, Cameron JL, Sohn TA, et al.: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997; 226: 248-257; discussion 257-260.
3. Sohn TA, Yeo CJ, Cameron JL, et al.: Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579.
4. Fatima J, Schnelldorfer T, Barton J, et al.: Pancreatoduodenectomy for ductal adenocarcinoma: Implications of positive margin on survival. Arch Surg 2010; 145: 167-172.
5. Garcea G, Dennison AR, Pattenden CJ, et al.: Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008; 9: 99-132.
6. Bouvet M, Gamagami RA, Gilpin EA, et al.: Factors influencing survival after resection for periampullary neoplasms. Am J Surg 2000; 180: 13-17.
7. Raut CP, Tseng JF, Sun CC, et al.: Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007; 246: 52-60.
8. Shoup M, Conlon K, Klimstra D, Brennan M:, Is extended resection for adenocarcinoma of the body or tail of the pancreas justified ? Journal of Gastrointestinal Surgery 2003; 7: 946-952.
9. Esposito I, Kleeff J, Bergmann F, et al.: Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2007; 15: 1651-1660.
10. Verbeke C:, Resection margins and R1 rates in pancreatic cancer-Are we there yet ? Histopathology 2008; 52: 787-796.
11. Verbeke CS, Menon KV:, Redefining resection margin status in pancreatic cancer. HPB (Oxford) 2009; 11: 282-289.
12. Garcea G, Dennison A, Ong S, et al.: Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of the pancreas. Eur J Surg Oncol 2007; 33: 892-897.
13. Butturini G, Stocken DD, Wente MN, et al.: Influence of resection margins and treatment on survival in patients with pancreatic cancer: Meta-analysis of randomized controlled trials. Arch Surg 2008; 143: 75-83; discussion 83.
14. Jamieson N, Foulis A, Oien K, et al.: Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 2010; 251: 1003-1010.
15. Washington K, Berlin J, Branton P, et al.: Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas. In: Pathologists CoA, editor, College of American Pathologists; 2011.
16. Takahashi T, Ishikura H, Motohara T, et al.: Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997; 65: 164-170.
17. Keleg S, Buchler P, Ludwig R, et al.: Invasion and metastasis in pancreatic cancer. Mol Cancer 2003; 2: 14.
18. Mitsunaga S, Hasebe T, Iwasaki M, et al.: Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci 2006; 96: 858-865.
19. Pawlik TM, Gleisner AL, Cameron JL, et al.: Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141: 610-618.
20. Bhatti I, Peacock O, Awan A, et al.: Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg 2010; 34: 768-775.
21. Sierzega M, Popiela T, Kulig J, Nowak K:, The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic cancer. Pancreas 2006; 33: 240-245.
22. Berger ACWJ, Ross EA, Hoffman JP:, The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2004; 70: 235-240.
23. Inoue K, Nakane Y, Iiyama H, et al.: The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9: 27-34.
24. Shimada K, Sakamoto Y, Sano T, et al.: Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma. Pancreas 2006; 33: 233-239.
25. Stocken DD, Buchler MW, Dervenis C, et al.: Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005; 92: 1372-1381.
26. Neoptolemos J, Stocken D, Dunn J, et al.: Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001; 234: 758-768.
27. Fisher WE, Hodges SE, Wu MF, et al.: Assessment of the learning curve for pancreaticoduodenectomy. Am J Surg 2011; 203: 684-690.
28. Millikan KW, Deziel DJ, Silverstein JC, et al.: Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 1999; 65: 618-623; discussion 623-614.
29. Verbeke CS, Leitch D, Menon KV, et al.: Redefining the R1 resection in pancreatic cancer. Br J Surg 2006; 93: 1232-1237.
30. Rau BM, Moritz K, Schuschan S, et al.: R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 2012; 152: S103-S111.
31. Hishinuma S, Ogata Y, Tomikawa M, et al.: Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 2006; 10: 511-518.
32. Van den Broeck A, Sergeant G, Ectors N, et al.: Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2009; 35: 600-604.